ResMed’s New QuietAir Diffuser Vent for CPAP Masks Reduces Noise by 89 Percent
ResMed (NYSE: RMD) (ASX: RMD) today introduced the QuietAir diffuser vent elbow, for its latest continuous positive airway pressure (CPAP) full face masks: AirFit F20 with silicone cushion and AirTouch F20 with memory foam cushion.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180510005362/en/
QuietAir reduces noise by 89 percent and produces a 70 percent gentler exhaled airflow, compared to ResMed’s previous design, allowing for a quiet, uninterrupted night of sleep and mitigating two barriers to therapy compliance: noise and bed partner comfort.
“With this technology, our full face masks’ noise levels are well below ambient noise in the bedroom,” said ResMed CEO Mick Farrell. “We are providing patients and their bed partners with the peace and quiet they deserve for better sleep.”
QuietAir is the latest innovation to ResMed’s line of AirFit and AirTouch products:
- AirTouch F20 with UltraSoft memory foam launched in May 2017 , creating a personalized fit with a uniquely soft and breathable seal, and fitting 98 percent of patients.
- AirFit F20 and AirFit N20 nasal masks launched in November 2016 to enhance facial comfort and fit, fitting 97 and 99 percent of patients, respectively, regardless of facial structure, gender or age.
All three masks complement ResMed’s suite of cloud-connected PAP devices: Air10 bedside machines and AirMini, the world’s smallest PAP device. Remote and self-monitoring, enabled by cloud connectivity, is proven to help improve patients adherence and clinicians’ business efficiencies.
QuietAir diffuser vents for AirFit F20 and AirTouch F20 masks are now available in the Americas, EMEA and Asia-Pacific. For more information, contact your ResMed sales representative.
ResMed (NYSE: RMD) (ASX: RMD), a world-leading connected health company with more than 5 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries. ResMed.com
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
MEYDAN-ONE12.12.2018 16:00 | Pressemeddelelse
Dubai’s Meydan One Takes Shape
JANSSEN12.12.2018 15:58 | Pressemeddelelse
New Phase 3 data demonstrate superiority of TREMFYA®▼ (guselkumab) vs Cosentyx® (secukinumab) in delivering PASI 90 responses in the treatment of moderate to severe plaque psoriasis at week 48
MA-FRISS12.12.2018 15:02 | Pressemeddelelse
FRISS Joins Duck Creek Partner Ecosystem to Provide Risk and Fraud Detection Solutions to Property & Casualty Insurers Worldwide
DC-VELODYNE-LIDAR-INC.12.12.2018 14:32 | Pressemeddelelse
David Hall Honored as “2018 Inventor of the Year” by Intellectual Property Owners Education Foundation
ALTASCIENCES12.12.2018 14:15 | Pressemeddelelse
Altasciences Contributes to Positive Top-Line Phase 1 Results for Chronic Cough Drug Candidate
NY-TAKEDA/NY-ACADEMY12.12.2018 14:02 | Pressemeddelelse
Takeda and the New York Academy of Sciences Announce 2019 Innovators in Science Award Winners
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum